Effect of atropine eye drops on thinning of the ocular choroid induced by retinal image defocus in adults with myopia (near-sightedness)
Effect of atropine eye drops on choroidal thinning induced by hyperopic retinal defocus in adults with myopia
The University of Auckland
12 participants
Nov 24, 2014
Interventional
Conditions
Summary
Myopia of any degree increases the risk of developing sight-threatening conditions such as glaucoma, retinal detachment and myopic maculopathy with risk increasing dramatically with progression to high myopia. Atropine eye drops are currently the most effective treatment for managing myopia progression, but the mode of action is unclear. The aim of this study was to investigate the effect of atropine eye drops on choroidal thinning induced by hyperopic retinal defocus, using automated measures of choroidal thickness obtained with swept-source optical coherence tomography (SS-OCT). A secondary aim was to record the short-term effect of atropine on the resting thickness of the choroid.
Eligibility
Exclusion Criteria1
- Individuals with amblyopia, ocular pathology or other ocular anomalies (e.g. surgery, trauma) that might have influenced the measurements were excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
One drop 0.5% atropine eye drop to non-dominant eye on one occasion, instilled by the research optometrist
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12617001519347